Aclaris Therapeutics (ACRS) Stock Insights

ACRS price $3.79 +0.01 +0.13%

Ticker
ACRS
Price
$3.79
Change
+0.01 +0.13%
Market cap ?
$558.62M
P/E ?
-6.49
Dividend yield ?
0.00%
Beta ?
0.80
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
46
Value
58
Quality
29
Growth
50

Stocklytics score rationale: value 58, quality 29, growth 50.

Financials

2016201720182019202020212022202320242025
01683000100910004227000648200067610002975200031249000187200007826000

Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial unmet needs in…

Fair value

ACRS fair value Not meaningful. Price $3.79.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ACRS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.16—1.23M
2026-08-06-0.15-0.161.63M1.38M
2026-05-07-0.15-0.162.00M1.32M
2026-02-26-0.16-0.151.29M2.07M
2025-11-06-0.12-0.133.30M2.07M
2025-08-07-0.13-0.131.78M1.14M
2025-05-08-0.12-0.171.46M3.55M
2025-02-27-1.01-0.329.21M2.11M
2024-11-06-0.11-0.084.35M2.12M
2024-08-07-0.15-0.192.77M1.82M
2024-05-07-0.24-0.282.40M1.37M
2024-02-27-0.02-0.3717.57M4.66M
2023-11-06-0.41-0.489.28M1.57M
2023-08-07-0.42-0.451.87M1.90M
2023-05-08-0.42-0.442.53M1.75M
2023-02-23-0.41-0.467.75M1.99M
2022-11-08-0.30-0.3919.02M1.60M
2022-08-03-0.31-0.361.53M1.61M
2022-05-10-0.31-0.391.45M1.60M
2022-02-24-0.37-0.361.50M1.79M
2021-11-02-0.35-0.271.66M1.77M
2021-08-05-0.34-0.261.82M1.75M
2021-05-07-0.57-0.271.78M1.73M
2021-02-25-0.31-0.281.58M1.40M
2020-11-04-0.25-0.291.45M1.69M
2020-08-07-0.28-0.342.05M2.63M
2020-05-07-0.36-0.291.41M1.22M
2020-02-25-0.46-0.341.09M949.00K
2019-11-07-0.56-0.54983.00K853.66K
2019-08-08-0.72-0.775.87M556.50K
2019-05-08-0.91-0.805.04M1.11M
2019-03-18-0.99-0.963.67M1.77M
2018-11-06-1.06-1.251.63M1.40M
2018-08-03-1.01-0.953.68M3.97M
2018-05-08-0.98-0.991.12M1.14M
2018-03-12-0.80-0.90999.00K1.23M
2017-11-07-0.63-0.86684.00K933.71K
2017-08-08-0.56-0.68——
2017-05-09-0.48-0.54——
2017-03-15-0.49-0.59——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-01Kolbeck Roland WilhelmSell36.38K——
2026-08-01Kolbeck Roland WilhelmBuy36.38K——
2026-08-01Kolbeck Roland WilhelmSell12.38K$5.2064.40K
2026-06-05Mehra AnandBuy11.58K——
2026-06-05SCHIFF ANDREW NBuy11.58K——
2026-06-05Mehra AnandSell11.58K——
2026-06-05SCHIFF ANDREW NSell11.58K——
2026-06-05Molineaux Christopher P.Buy11.58K——
2026-06-05Humphries William D.Buy11.58K——
2026-06-05Humphries William D.Sell11.58K——
2026-06-05Molineaux Christopher P.Sell11.58K——
2026-06-05MILANO VINCENTBuy11.58K——
2026-06-05MILANO VINCENTSell11.58K——
2026-06-05GOWEN MAXINEBuy11.58K——
2026-06-05GOWEN MAXINESell11.58K——
2026-06-04SCHIFF ANDREW NBuy42.35K$4.71199.47K
2026-06-04Mehra AnandBuy42.35K$4.71199.47K
2026-06-04Mehra AnandBuy10.99K——
2026-06-04SCHIFF ANDREW NBuy10.99K——
2026-06-04Humphries William D.Buy42.35K$4.71199.47K
2026-06-04Molineaux Christopher P.Buy42.35K$4.71199.47K
2026-06-04Molineaux Christopher P.Buy10.99K——
2026-06-04Humphries William D.Buy10.99K——
2026-06-04MILANO VINCENTBuy42.35K$4.71199.47K
2026-06-04MILANO VINCENTBuy10.99K——
2026-06-04GOWEN MAXINEBuy42.35K$4.71199.47K
2026-06-04GOWEN MAXINEBuy10.99K——
2026-05-01Hall Jesse WayneSell36.38K——
2026-05-01Hall Jesse WayneBuy36.38K——
2026-05-01Hall Jesse WayneSell9.33K$4.4141.15K
2026-04-23Leonard Braden MichaelSell300.00K$4.531.36M
2026-03-01Balthaser KevinBuy2.38K——
2026-03-01Balthaser KevinSell677$2.871.94K
2026-03-01Balthaser KevinSell2.38K——
2026-02-03Loerop JamesBuy20.88K——
2026-02-03Loerop JamesSell5.94K$3.4720.60K
2026-02-03Loerop JamesSell20.88K——
2026-02-03Walker NealBuy63.48K——
2026-02-03Walker NealSell18.61K$3.4764.58K
2026-02-03Walker NealSell63.48K——
2026-02-03Davis Hugh M.Sell18.68K——
2026-02-03Davis Hugh M.Buy18.68K——
2026-02-03Balthaser KevinBuy22.02K——
2026-02-03Balthaser KevinSell6.45K$3.4722.38K
2026-02-03Balthaser KevinSell22.02K——
2026-02-02Walker NealBuy961.70K$3.613.47M
2026-02-02Walker NealBuy274.80K——
2026-02-02Davis Hugh M.Buy336.30K$3.611.21M
2026-02-02Davis Hugh M.Buy96.10K——
2026-02-02Kolbeck Roland WilhelmBuy334.90K$3.611.21M
2026-02-02Kolbeck Roland WilhelmBuy95.70K——
2026-02-02Hall Jesse WayneBuy343.30K$3.611.24M
2026-02-02Hall Jesse WayneBuy98.10K——
2026-02-02Loerop JamesBuy341.90K$3.611.23M
2026-02-02Loerop JamesBuy97.70K——
2026-02-02Balthaser KevinBuy346.80K$3.611.25M
2026-02-02Balthaser KevinBuy99.10K——
2026-02-01Loerop JamesBuy14.75K——
2026-02-01Loerop JamesSell10.69K$3.5137.51K
2026-02-01Loerop JamesBuy7.50K——
2026-02-01Loerop JamesBuy11.25K——
2026-02-01Loerop JamesSell14.75K——
2026-02-01Loerop JamesSell7.50K——
2026-02-01Loerop JamesSell11.25K——
2026-02-01Balthaser KevinBuy14.75K——
2026-02-01Balthaser KevinSell4.98K$3.5117.49K
2026-02-01Balthaser KevinSell14.75K——
2026-01-02Walker NealBuy29.15K——
2026-01-02Walker NealSell9.95K$2.8828.66K
2026-01-02Walker NealSell29.15K——
2026-01-02Loerop JamesBuy18.15K——
2026-01-02Loerop JamesSell6.17K$2.8817.77K
2026-01-02Loerop JamesSell18.15K——
2026-01-02Balthaser KevinBuy13.20K——
2026-01-02Balthaser KevinSell4.46K$2.8812.85K
2026-01-02Balthaser KevinSell13.20K——
2026-01-01Balthaser KevinBuy7.50K——
2026-01-01Balthaser KevinSell2.25K$3.016.77K
2026-01-01Balthaser KevinSell7.50K——
2025-12-31Loerop JamesBuy73.75K——
2025-12-31Loerop JamesSell33.99K$3.01102.32K
2025-12-31Loerop JamesSell73.75K——
2025-12-31Balthaser KevinBuy73.75K——
2025-12-31Balthaser KevinSell19.93K$3.0160.00K
2025-12-31Balthaser KevinSell73.75K——
2025-12-02Davis Hugh M.Sell26.75K——
2025-12-02Davis Hugh M.Buy26.75K——
2025-08-01Kolbeck Roland WilhelmBuy510.00K$1.53780.30K
2025-08-01Kolbeck Roland WilhelmBuy145.50K——
2025-07-28Kolbeck Roland WilhelmOther0——
2025-06-06SCHIFF ANDREW NBuy4.79K——
2025-06-06SCHIFF ANDREW NSell4.79K——
2025-06-06MILANO VINCENTBuy4.79K——
2025-06-06MILANO VINCENTSell4.79K——
2025-06-06Mehra AnandBuy4.79K——
2025-06-06Mehra AnandSell4.79K——
2025-06-06Humphries William D.Buy4.79K——
2025-06-06Humphries William D.Sell4.79K——
2025-06-06GOWEN MAXINEBuy4.79K——
2025-06-06GOWEN MAXINESell4.79K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 156, holders +16 vs prior quarter. Ownership 83.71%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.12.72M5.92M+86.99%67.30M
BML CAPITAL MANAGEMENT, LLC11.97M-2.27M-15.96%63.35M
BLACKROCK, INC.10.04M2.63M+35.51%53.10M
DEEP TRACK CAPITAL, LP9.35M00.00%49.44M
VIVO CAPITAL, LLC6.69M27.97K+0.42%35.41M
VANGUARD CAPITAL MANAGEMENT LLC5.82M650.40K+12.59%30.78M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.4.93M00.00%26.06M
ROCK SPRINGS CAPITAL MANAGEMENT LP4.33M-142.12K-3.18%22.91M
ADAGE CAPITAL PARTNERS GP, L.L.C.4.07M200.00K+5.17%21.54M
DECHENG CAPITAL LLC4.04M00.00%21.38M
STATE STREET CORP3.26M1.25M+62.06%17.22M
GEODE CAPITAL MANAGEMENT, LLC3.19M766.37K+31.62%16.88M
BRAIDWELL LP2.14M443.23K+26.09%11.33M
BALYASNY ASSET MANAGEMENT L.P.2.02M-1.34M-39.80%10.70M
SILVERARC CAPITAL MANAGEMENT, LLC1.95M1.95MNew10.30M
KALEHUA CAPITAL MANAGEMENT LLC1.83M00.00%9.69M
CITADEL ADVISORS LLC1.76M1.66M+1622.46%9.32M
JONES HILL CAPITAL LP1.76M1.76MNew9.31M
ACADIAN ASSET MANAGEMENT LLC1.64M101.68K+6.60%8.68M
PALO ALTO INVESTORS LP1.61M00.00%8.54M
WOODLINE PARTNERS LP1.61M125.43K+8.44%8.52M
VANGUARD PORTFOLIO MANAGEMENT LLC1.47M-190.33K-11.49%7.75M
PANAGORA ASSET MANAGEMENT INC1.36M853.86K+169.99%7.17M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.21M-208.47K-14.70%6.40M
MPM BIOIMPACT LLC1.04M650.55K+165.99%5.51M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Aclaris Therapeutics (ACRS) Stock Insights

ACRS$3.79+0.01 +0.13%

$558.62M

Market Cap

-6.49

P/E

—

Forward P/E

46

Score

Price History